OUR NEW SITE IS
Current cancer treatments can be ineffective and cause debilitating side effects.
Chimeric Designs is developing multifunctional and targeted therapeutics to improve the health and well-being of patients with cancer.
13% of non-Hodgkin’s Lymphoma cancer patients die from the direct effects of chemotherapy in the first 30 days of treatment. Chimeric Designs is working towards making chemotherapy treatment work more efficiently.